Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That would make TWO bets that you've lost.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.017
0.0002 (1.19%)
Volume: 93,508
Last Trade Time: 3:00:43 PM EDT
Total Trades: 9
Dollar volume: $ 1,450
They did more business today at my local deli without the aid of any market makers or message board promoters.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0168
-0.0001 (-0.59%)
Volume: 23,092
Day Range: 0.0162 - 0.0168
Total Trades: 10
Lotsa demand built up over the weekend.
Dollar Volume: $384
Sure.
https://www.masscourts.org/eservices/home.page.2
Superior Court
Essex County
2077CV00101
Appreciate the interest.
Edit: I figured the Cost stuff was just boilerplate but I get your point.
Thanks. But that leaves me wondering why the parties would then stipulate to the dismissal of a single count on the same day and under the same docket number.
If there's a board better suited to respond to this please advise.
I'm hoping someone can interpret some legalese involving Innovation Pharmaceuticals (IPIX).
For background: The Company rented some space and based on a clause in their lease it was automatically renewed. That's the primary issue in the case..failure to give notice of their intent to vacate.
The bench trial just started and one of the early docket entries reads this way:
In case this is behind a paywall I'll paste an excerpt or two. It's an OPINION piece from today's NY Times and the excerpts may show my own personal bias. I can post the entire piece if requested.
https://www.nytimes.com/2023/09/11/opinion/india-medicine-safety.html
"Over the past two decades, India emerged as the “pharmacy of the developing world,” the leading manufacturer of generic drugs and medicines, producing more than 20 percent of the world’s supply. This has helped to make a range of medicines available to poor patients around the world who previously had to do without.
Today, however, India stands accused of distributing death, as its regulators fail to prevent the manufacture and export of substandard medicines. But this isn’t entirely a made-in-India problem. There is a dirty secret in global health: Rich countries get quality medicines, the poor sometimes get poison."
"Last month, a Gambian government task force recommended suing the Indian government over deadly cough syrup. Yet the administration of Prime Minister Narendra Modi of India last month pushed a bill through Parliament that features lighter punishments for manufacturing substandard medicines, highlighting why individual nations cannot be relied on to address the problem.
India needs to clean up its act for its own good — its growth into a powerhouse of generic drug production has polluted its rivers with antibiotic waste, spawned dangerous superbugs and made it a global hot spot for drug-resistant tuberculosis. For the rest of the world, the main benefit of India becoming the pharmacy of the poor was to break Big Pharma’s control of lifesaving medicines. More cases involving deadly Indian-made medicines could undo that positive achievement by causing irreparable harm to the global reputation of cheap generics."
I'm sure if it was peer reviewed you would have made much of it. It was a pre-print and you made no mention of it even though the publishers themselves recognized its significance.
Papers, researchers, university labs WOOHOOOO!!
None of it adds up to be worth a Phase 3 trial...which LE has spent his entire career avoiding. I expect he has had good reasons. Just think about it.
That paper MAY be fine but they put this in bold red type at the top of the page for a reason:
This version is not peer-reviewed
As I understand it, yes. A small good thing.
Not sure why it happened but they may have agreed that to pursue it would benefit the lawyers more than the parties.
Like "Let's just skip this and move on".
Per trial docket:
"Maybe your boss has the money...."
I don't have one of those. Haven't had one since 1976.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0169
0.0001 (0.60%)
Volume: 240,871
Day Range: 0.0168 - 0.017
Last Trade Time: 3:50:59 PM EDT
Total Trades: 24
That 10,000 shares you bought today (for less than 200 smackers) is worth what now, another buck?
Wohoooo!!!
The only way to prove the potential of something is to accomplish that potential.
This Company has never done that with any of its drugs....just ask the FDA.
"If the Phase 2 trial is not successful the drug did not prove its potential."
Who declares that a Phase 2 trial is successful? You? Leo? The FDA?
Is there a list of successful Phase 2 trials that you can point me to? Of course not.
Language IS important but this is not a word game.
An unmarketed drug has not proven its potential. A drug that hasn't made it into the health care system has not achieved the desired goal of the developer.
A Phase 2 trial is successful (in the USA) if it provides adequate bases for the procession to a Phase 3 trial. IPIX has never conducted a Phase 3 trial, much less marketed a drug.
Your continual use of the terms proven and successful is deceptive.
ps.Your source is from the Netherlands, frenchbroad....maybe they perceive things differently there.
The pot is calling the kettle black.
You quoted the poster correctly.....
"The remaining drugs have never proven their potential in human trials"
.....and the poster was perfectly correct.
If the Company itself said the following the FDA could have something to say about it and the Rosens (remember them) of the world might as well:
"Brilacidin: Successful and safe trials for 3 different human malady with 3 different administer methods. "
Completion of a Phase 2 trial should only be described as the successful completion of a Phase 2 trial, nothing more and nothing less. Neither Brilacidin nor any other IPIX drug has proven its potential in a human trial.
That poster's language was accurate and you may not have liked the import of it but it was VERY wrong of you to say this:
"Your language is poor:"
Language is important. Proven and potential are words that have meanings that are especially important when it comes to pharmaceuticals.
It's low all right.
bonne chance......
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0168
0.0016 (10.53%)
Volume: 792,235
Day Range: 0.015 - 0.017
Last Trade Time: 3:49:42 PM EDT
Total Trades: 61
"Walking away with 60%+ gains after less than a month's time doesn't happen that often"
Did you really do that? If so, during what month?
"Are you saying that he "gave" them company money for free ?"
The terms of the "gift" were made public in an SEC filing. Need a link?
Whoops! Almost forgot:
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0152
0.0001 (0.66%)
Volume: 381,208
Last Trade Time: 2:58:28 PM EDT
Total Trades: 16
Consider that not everyone lives in your time zone, 007.
OR people who are willing to contribute their time and effort to assist in the enforcement of the rules on behalf of Ihub should be granted a basic membership that provides PM privileges.
Then again I guess that might be construed to be compensation which could defeat the purpose of having moderators.
Never mind :o)
Not by the person I asked, no. But it didn't need to be asked...this isn't at all confusing so I'm acting accordingly in both my posting and my moderating:
"Boards are to discuss the company/stock - not other Users and/or the message board."
If my deletions are reversed (as they have been) I guess I'll just have to grin and bear it. I wouldn't want to be demoderatored. That said I don't think we've heard the last of the issue. I hope the wording of the Handbook will conform to (or refute) the above statement at some point. Then we'll be able to perform our respective functions and move on with some clarity.
Force of habit....and it's very lucrative.
Only one variable in the routine: "a pretty nifty way to both transfer some cash out of a US entity into _____"
The blank gets filled in with the AD owned entity du jour.
It's this CEO's version of the old "Keep your eye on the birdy" trick and it's working here (for the umpteenth time).
When was the last time he finished something he started?
8-K filed explaining $1.5M left pocket to right pocket milestone payment....
except it's a note, not a payment, and it carries 12% interest.
Recap as I understand it:
NNVC signs new License agreement with TheraCour to cover Covid drug development.
AD goes to India and hires a company in which he is a principal to develop and run a Phase 1 for NNVC's covid drug.
NNVC issues note to Theracour for milestone payment amount of $1.5M.
"No one has been willing to anti up, yet for Brilicidin"
Everybody knows that...it was the basis for the posters question: Why not?
Does Big Pharma have safety concerns? Or efficacy questions? Or both?
It's just not reasonable to think that the IPIX Board of Directors is rejecting offers when the Company is basically broke.
I think it's important to distinguish between posts in which a poster is attacked and a post which merely discusses another poster but is also bereft of any Company related discussion. The latter may not be an attack but it doesn't conform to the purported mission of the Board: "InvestorsHub ("iHub", as we call it) is built to provide a forum for serious investors to gather and share market insights". (highlights mine)
That hasn't changed, has it?
A perfect example and it's hot off the presses:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172745100
Not a word about the Company that is supposed to be the subject of the board.
What's a Moderator to do?
"For other Ipix owners like me what do you want to tell persons interested in Ipix that come here for information?"
You've been careful to eliminate me from your solicitation but I have an idea for you anyway. How about authoring a post that links the latest IPIX PR: "Innovation Pharmaceuticals Announces New Milestone at BeaMed"?
The interested persons could then, if they read the PR carefully, come to the realization that this Company considers being ready to do something but not yet doing it a milestone. A perfect introduction to IPIX if you ask me.
ps. Happy Moderating!
"Boards are to discuss the company/stock - not other Users and/or the message board."
That's what I thought...or used to think. That's the easiest rule to enforce yet this moderator has had a bunch of his deletions for clear violations of it restored. As a result I've resorted to using the Report feature, as we were advised to do when we aren't sure. More often than not (by far) the offending post remains, reinforcing the sense that I'm not clear on what the rules really are and putting the workload that mods were supposed to relieve back in the hands of Admin.
The simple rule is nowhere to be found in the Moderator's Guidelines:
https://ihwiki.advfn.com/index.php?title=Moderators%27_Guidelines
Shouldn't it be there, just as you stated it, as Rule #1?
"The major question is not IF Brilacidin is a wonderful drug"
It's not? Of course that's the question....and so far the answer is a decisive and emphatic "no". Without a Phase 3 there can be no other answer.
Good post otherwise.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0155
-0.0004 (-2.52%)
Volume: 203,717
Total Trades: 16
Trading volume: $ 3,130
You're talking to the wrong guy.
By the way, I have advised you several times as to how you could become a moderator and join the fun yet you seem to find it more important to complain about an imagined inability to do so.
Come on in, the water's fine.
Knock yourself out. I would hope that any newbies who stumbled over your post would recognize that it says nothing about iPIX at all.
I thought that this was the main issue and I try to touch on it regularly: IPIX $.0159
With regular references to:
https://www.sec.gov/edgar/browse/?CIK=1355250&owner
and
http://www.ipharminc.com/
....ferreting out as much misinformation as I can, even going as far as to finding the press releases that this CEO tries to make disappear.
Any comments about a CEO who does that, by the way? If the main issue ($.0159) is a function in large part to management's credibility you should want me to touch on that, no?
"No one else has a good new one to speak about." Interesting deduction.
And he has less than 25 minutes to talk about it. Think he can fit in ALL the good news about the pre-clinical B anti-fungal testing?
"I think it is pertinent that a call for free speech seems to have touched some mighty sensitive nerves."
Nobody tried to discourage anyone from speaking.
People can lie here....
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172729499
or be 100% wrong here....
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172730651
and as you have just proven can set up straw men here......with impunity.
"There is ONLY ONE reason for ANY person to spend time and days and years to follow and monitor and discuss one company and company activity and share price.
They have current financial interest in success or failure of this company. "
That's just wrong...factually false. Fortunately it is a lot less expensive than your other mistake.
Zero creativity. Don't you think it's kind of sad when you have to copy your insults from another board?
Everybody makes mistakes. You aren't the only one to have made this one....you have plenty of company, some of whom have learned from theirs.
It really shouldn't be taking this long.
IPIX Historical Summary
Period Open High Low VWAP Avg. Daily Vol Change %
1 Week 0.0142 0.016 0.0101 0.0142981 448,927 0.0015 10.56%
1 Month 0.0174 0.0174 0.0101 0.0151379 354,069 -0.0017 -9.77%
3 Months 0.0168 0.021 0.0101 0.016831 261,507 -0.0011 -6.55%
6 Months 0.0178 0.03 0.0101 0.0174229 323,584 -0.0021 -11.8%
1 Year 0.04096 0.044 0.0101 0.0221196 482,922 -0.02526 -61.67%
3 Years 0.22 0.54 0.0101 0.1651064 1,292,589 -0.2043 -92.86%
5 Years 0.418 0.65 0.0101 0.1815443 1,305,263 -0.4023 -96.24%
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0157
0.002775 (21.47%)
Volume: 394,292
Total Trades: 31
Dollar Volume: $5,772
Woohooo!